Fate Therapeutics FATE
NASDAQ FATE
$2.30 -0.07 (-2.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Long-Term Debt Issuances (2013 - 2014)

Updated

Fate Therapeutics' Long-Term Debt Issuances came in at $15 million for FY2017, up 50.0% from $10 million in FY2016.

Analysis

Fate Therapeutics (FATE) Long-Term Debt Issuances (2013 - 2014) Analysis & Trends

Going back to FY2011, Fate Therapeutics' Long-Term Debt Issuances data covers 6 years.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of -10.8% (FY2013 to FY2017).
  • The FY2017 figure represents the highest annual Long-Term Debt Issuances since FY2014.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $10 million in FY2016 (unchanged), $10 million in FY2015 (-50.0%), $20 million in FY2014 (-15.7%) and $23.74 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Fate Therapeutics 276.57 Mn 276.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 10.00 Mn
Sep 30, 2013 20.74 Mn
API Access

Fate Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=FATE&period=max&api_key=YOUR_API_KEY